|
"international multi-center clinical trials" conference will be held on dec.9th-10th in shanghai
"international multi-center clinical trials" conference, initiated by noppen and co-organized by shanghai clinical research center (scrc) will be held on dec.9th-10th in shanghai.
event brief
international multi-center clinical trials are considered a quick method for pharmaceutical companies to get their products into the global market. currently, over 15,000 global clinical trials are being conducted in the larger asian pacific market, which includes a growing number of trials conducted in china. according to the sfda, there is increasing popularity to use china as a location for clinical trials, and many more pharmaceutical companies are also choosing china as their global clinical trial center.
to provide an inside view into global clinical trials in china, the "international multi-center clinical trials" conference, as the 4th annual conference in noppen´s clinical trial series, will act as a platform to help you optimize global clinical processes while ensuring regulatory compliance; provide you with knowledge of changing government regulations and help you build a clinical strategy to successfully introduce your products quickly to the market.
major issues to be addressed at the 2010 event
session a: clinical trials go global - china´s clinical trial environment analyses
session b: global clinical trial preparation, design, and clinical operation
session c: innovative trial design and trial data management
session d: issues in imct and key points to note
session e: panel discussion: partnership between pharmaceutical companies and hospitals -- building mutually beneficial relations
session f: medical imaging in clinical trials and surrogate end point discussions
session g: pharmacoeconomics in clinical trials
session h: ethical issues in global clinical trials
session i: global trials safety surveillance and risk management
session j: panel discussion: challenges and advantages of global clinical trials in china
for more information, please refer to the website below:
|
